Overexpression of cell surface glycoproteins of the CD44 family is an early
event in the colorectal adenoma-carcinoma sequence. This suggests a Link w
ith disruption of APC tumor suppressor protein-mediated regulation of beta-
catenin/Tcf-4 signaling, which is crucial in initiating tumorigenesis. To e
xplore this hypothesis, we analyzed CD44 expression in the intestinal mucos
a of mice and humans with genetic defects in either APC or Tcf-4, leading t
o constitutive activation or blockade of the beta-catenin/Tcf-4 pathway, re
spectively. We show that CD44 expression in the non-neoplastic intestinal m
ucosa of Apc mutant mice is confined to the crypt epithelium but that CD44
is strongly overexpressed in adenomas as well as in invasive carcinomas. Th
is overexpression includes the standard part of the CD44 (CD44s) as well as
variant exons (CD44v). Interestingly, deregulated CD44 expression is alrea
dy present in aberrant crypt foci with dysplasia (ACFs), the earliest detec
table lesions of colorectal neoplasia. Like ACFs of Apc-mutant mice, ACFs o
f familial adenomatous polyposis (FAP) patients also overexpress CD44, In s
harp contrast, Tcf-4 mutant mice show a complete absence of CD44 in the epi
thelium of the small intestine. This loss of CD44 concurs with loss of stem
cell characteristics, shared with adenoma cells. Our results indicate that
CD44 expression is part of a genetic program controlled by the beta-cateni
n/Tcf-4 signaling pathway and suggest a role for CD44 in the generation and
turnover of epithelial cells.